Home  |  Corporate Info  |  R & D  |  Products  |  Investor Relations  |  For the Patient  |  Careers at Hemispherx  


Officers and Directors
Officers and Directors Bios
Scientific Advisory Board
Hemispherx Biopharma Locations
Key Contacts
Alliances

 

Corporate Alliances

Chronix Biomedical
Alliance: CFS, Gulf War Syndrome, Hepatitis B & C

GP Pharm Latinoamerica
 Alliance: An exclusive revenue sharing Sales, Marketing, Distribution and Supply Agreement for Argentina and Mexico with Hemispherx for Alferon N® and Ampligen®.

Hollister-Stier Laboratories LLC
Alliance:  Contract manufacturing of Hemispherx’s experimental drug, Ampligen®

Max Neeman International
 Alliance:  Clinical Research Organization, India:  Alferon N Injection® for treatment of seriously ill patients hospitalized with either seasonal influenza or pandemic influenza

National Institute of Infectious Diseases, Tokyo, Japan
Alliance:  Avian Influenza

 
Information contained on the Hemispherx website other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed on the Hemispherx website and in the Company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements. Additionally, all the referenced investigational drugs and associated technologies of the company are experimental in nature and as such are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials with the referenced disorders. The forward-looking statements represent the Company's judgement as of the date of this website. The Company disclaims, however, any intent or obligation to update these forward-looking statements.